| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 2 | SEC Filings | ||
| Do | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year | 6 | GlobeNewswire (USA) | ||
| 28.01. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 10 | SEC Filings | ||
| 28.01. | Intelligent Bio Solutions begins clinical studies for FDA clearance | 2 | Investing.com | ||
| INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 28.01. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market | 119 | GlobeNewswire (Europe) | Clinical studies designed to support FDA clearance and planned commercial launch into the world's largest drug screening market Company anticipates full data analysis by the end of March 2026; data... ► Artikel lesen | |
| 08.01. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 02.01. | Intelligent Bio Solutions sichert sich 10 Millionen US-Dollar durch Privatplatzierung | 5 | Investing.com Deutsch | ||
| 02.01. | Intelligent Bio Solutions closes $10 million private placement | 4 | Investing.com | ||
| 02.01. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 3 | GlobeNewswire (USA) | ||
| 02.01. | INBS Stock Surges 132.4% on New Manufacturing Partnership | 4 | Zacks | ||
| 02.01. | Stock Market Today: S&P 500, Dow Futures Gain On The First Trading Day Of 2026- Baidu, Rubico, Intelligent Bio Solutions In Focus | 14 | Benzinga.com | ||
| 31.12.25 | Intelligent Bio Solutions launches $10M private placement | 2 | Seeking Alpha | ||
| 31.12.25 | Aktie von Intelligent Bio Solutions bricht nach 10-Millionen-Dollar-Privatplatzierung ein | 3 | Investing.com Deutsch | ||
| 31.12.25 | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 4 | GlobeNewswire (USA) | ||
| 31.12.25 | Intelligent Bio Solutions Stock Surges 188% On New Manufacturing Partnership | 1 | RTTNews | ||
| 31.12.25 | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.12.25 | Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts | 1 | Benzinga.com | ||
| 31.12.25 | INBS partners with Syrma Johari to boost production, improve margins | 2 | Investing.com | ||
| 31.12.25 | INBS schließt strategische Partnerschaft mit Syrma Johari zur Produktionssteigerung und Margenverbesserung | 4 | Investing.com Deutsch | ||
| 31.12.25 | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | 1.051 | GlobeNewswire (Europe) | NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,440 | +1,65 % | Picks and shovels play intact, chg.: FY25 prelims confirm Eckert & Ziegler's earnings momentum, with China and isotope ... | Novo Nordisk's c.17% share price drop underscores how quickly sentiment can turn in single product healthcare stories, especially when patent cycle concerns resurface. In contrast, EUZ is "picks and... ► Artikel lesen | |
| DRAEGERWERK | 86,30 | -0,46 % | DAX wartet auf Fed - Airbus, Bayer, Drägerwerk, Infineon, SUSS Microtec, Wacker Chemie im ... | Am deutschen Aktienmarkt herrscht zu Handelsbeginn wenig Bewegung - die Anleger warten gespannt auf die nächste Notenbankentscheidung in den USA heute Abend. Am Vortag scheiterte der DAX zudem an der... ► Artikel lesen | |
| TELADOC HEALTH | 4,240 | -0,05 % | Teladoc Health, Inc.: Teladoc Health to Announce Fourth Quarter 2025 Financial Results | ||
| ROKU | 73,07 | +0,63 % | This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday | ||
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Hims & Hers-Aktie -10%: Warum profitiert sie nicht? | Die Hims & Hers-Aktie schoss am gestrigen Donnerstag kurzfristig um über +10% in die Höhe, beendete den Handelstag dann aber doch mit einem Minus von fast -4%. Am Freitagmorgen bricht der Kurs der Gesundheitsplattform... ► Artikel lesen | |
| BICO GROUP | 1,594 | -0,25 % | BICO Group AB: BICO company Biosero launches GoSimple, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) | Biosero, part of the BICO Group and a leader in lab automation, will launch the GoSimple workcell at SLAS 2026 (February 7-11, Boston, US). GoSimple is a standardized, automation-ready workcell designed... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,086 | -7,53 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,670 | -2,20 % | GERATHERM MEDICAL AG - Schwäche im aktuellen Marktumfeld | ||
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 158,00 | -0,47 % | Align Technology Inc. Announces Increase In Q4 Bottom Line | WASHINGTON (dpa-AFX) - Align Technology Inc. (ALGN) reported a profit for its fourth quarter that Increases, from last yearThe company's earnings came in at $135.76 million, or $1.89 per share.... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,019 | +7,87 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,256 | +10,65 % | Plus Therapeutics Inc.: Plus Therapeutics Provides Business Update on REYOBIQ Clinical Program and U.S. CNSide Commercialization | HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| HEALWELL AI | 0,450 | +1,58 % | HEALWELL AI: HEALWELL AI Provides Additional Information Regarding November 3, 2025, Release Where it Announced Strategic Divestments | Toronto, Ontario--(Newsfile Corp. - December 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 02.02.2026 | The following instruments on XETRA do have their first trading 02.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.02.2026
Aktien
1 CA00249P1053 AXA S.A. CDR
2 ARP125991090... ► Artikel lesen | |
| SPINEWAY | 0,171 | +6,06 % | SPINEWAY: 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) | Ecully, January 13, 2026 - 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros20252024Change as a %H1 revenue5,5736,535-15%H2... ► Artikel lesen |